Health Products

Dimension Vista System - Gentamicin Assay, Dimension Clinical Chemistry System - Gentamicin, Dimension Xpand System - Genamicin (Gent) Assay, Dimension EXL System Gentamicin (Gent) Assay (2018-04-24)

· Published by Health Canada · Official notice

Details

Alert type: Medical Device Recall
Category: Medical Device
Issue: Medical Devices
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type III
Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

Lot or serial numberCompaniesBrand nameModel or catalog number
BB8159
Manufacturer
Siemens Healthcare Diagnostics Inc.
500 GBC DRIVE, MAILSTOP 514, P.O. BOX 6101
Newark
19714
Delaware
UNITED STATES
D. Dimension EXL System - Gentamicin (Gent) AssayDF12
BB8159
Manufacturer
Siemens Healthcare Diagnostics Inc.
500 GBC DRIVE, MAILSTOP 514, P.O. BOX 6101
Newark
19714
Delaware
UNITED STATES
B. Dimension Clinical Chemistry System - GentamicinDF12
BB8159
Manufacturer
Siemens Healthcare Diagnostics Inc.
500 GBC DRIVE, MAILSTOP 514, P.O. BOX 6101
Newark
19714
Delaware
UNITED STATES
C. Dimension Xpand System - Gentamicin (Gent) AssayDF12
12269BD
Manufacturer
Siemens Healthcare Diagnostics Inc.
500 GBC DRIVE, MAILSTOP 514, P.O. BOX 6101
Newark
19714
Delaware
UNITED STATES
A. Dimension Vista System - Gentamicin AssayK4012

Introduction

Affected products
  1. Dimension Vista System - Gentamicin Assay
  2. Dimension Clinical Chemistry System - Gentamicin
  3. Dimension Xpand System - Gentamicin (Gent) Assay
  4. Dimension EXL System - Gentamicin (Gent) Assay

Reason

Siemens Healthcare Diagnostics has confirmed Dimension Gentamicin (Gent) lot bb8159 may exhibit inaccuracy for Quality Control (QC) and patient samples at the low end of the analytical measurement range. Maximum negative bias of 100% and 48% were observed for patient samples at 0.9 ug/ml [1.94 umol/l] and 1.9 ug/ml [4.1 umol/l], respectively. Patient samples at 2.6 ug/ml [5.62 umol/l] did not show a bias. The bias is due to the calibration curve not showing separation between the level 1 and level 2 calibrators. Based on the investigation, lots 17135bc, 17150bf, 17159bd, 17178ac, 17269bd, and 17312bb may also exhibit a similar separation between level 1 and level 2 calibrators over time.
Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime